|
||
|
||
| [Home Page] [Previous Menu] [Search] |
Contained
Use of GMOs and pathogens
Laboratory-acquired Infections
(Last revised:
November 8, 2006
)
Table 1 summarizes the most frequently recorded cases of laboratory-acquired infections. See references page for some of these pathogenic micro-organisms.
Table 1 : the "top ten" laboratory-acquired infections (from 1979 to 1999)
Biological agent° |
Class of risk or risk group°° |
Disease |
|---|---|---|
| Brucella spp. | 3 |
Brucellosis |
| Coxiella burnetii | 3 |
Q fever |
| Hepatitis B, C and D viruses | 3* |
Hepatitis |
| Salmonella thyphi | 3* |
Typhoid fever |
| Francisella tularensis | 3 |
Tularaemia |
| Mycobacterium tuberculosis complex | 3 |
Tuberculosis |
| Trycophyton mentagrophytes | 2 |
Dermatomycosis |
| Venuzeelan equine encephalitis virus | 3 |
Venezuelan equine encephalitis |
| Chlamydia psittaci (avian) | 3 |
Psittacosis |
| Coccidioides immitis | 3 |
Coccidioidomycosis |
(adapted from Collins, 1998 and Harding & Brandt Byers, 2000)
3* : class of risk 3 infectious agents that are normally not airborne pathogens.
°the biological agents reported in Table 1 are linked, when available, to the corresponding Material Safety Data Sheet (MSDS) from the Office of Laboratory Security, Health Canada.
°°Classes of risk are given for human. For Belgian classifications of micro-organisms based on their biological risk follow this link (Belgian Biosafety Server)
|